Advertisement

Topics

Companies Related to "Factors Driving Global Acromegaly Gigantism Drugs Market Technavio" [Most Relevant Company Matches] RSS

08:06 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "Factors Driving Global Acromegaly Gigantism Drugs Market Technavio" found in our extensive corporate database of over 50,000 company records.

Showing "Factors Driving Global Acromegaly Gigantism Drugs Market Technavio" Companies 1–25 of 8,700+

Extremely Relevant

TechNavio

TechNavio is a leading global technology research and advisory company.


TechNavio Research

TechNavio is a leading global technology research and advisory company.

Relevant

Strongbridge Biopharma plc

Following the successful completion of its exchange offer to acquire the issued ordinary shares of Cortendo AB, Strongbridge Biopharma is now the new parent company of the Cortendo group. The group’s strategic focus is to build a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complemen...


ADAllen Pharma Ltd

ADAllen Pharma Ltd specialise in sourcing comparator drugs for clinical trials. As a clinical tirals supplier for the pharmaceutical market, we have extensive knowledge of the global pharmaceutical market and of the many issues involved in the procurement of comparator drugs. We specialise in the sourcing and distribution of comparators for the clinical trials industry and other pharmaceutical su...

Caprologics

Capralogics has manufactured a variety of novel polyclonal antibodies against Cell Membrane Receptors, Nuclear Components, Apoptosis Factors, Neuropeptides, Oncoproteins, Signaling Intermediates, Transcription Factors and Proteins Involved in Infectious D

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, reproductive medicine, and women’s health. Its pioneering small molecule somatostatin agonist program for the treatment of acromegaly and neuroendocrine tumors aims to provide...

BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) is a non-profit organization whose mission is to save lives by accelerating the development of novel drugs, vaccines, and diagnostics coming from the biotechnology industry that address the unmet medical needs of the developing world. We work at the crossroads of biotechnology and global health to find the common ground ...

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...

Biopharmacopae

For centuries plants have been a very important source of medications. Less than 5% of the 300,00 plant species have ever been investigated for their medicinal properties. An estimated one-quarter of the prescription drugs contain active ingredients derived from plants. Widely used drugs from plant extracts include the antibiotic, immunosuppressant, and the anti-anti cancer agents. Global over the...

TGR BioSciences Pty Ltd

We have a particular interest in gut and skin disorders where products can be delivered locally by ingestion or by topical application. Where possible, we take these products to market as dietary supplements, medical foods or skin care products because the time and cost to market is much less than with drugs.Our products include novel milk-derived bioactive extracts as ingredients for cosmetic and...

Gene Network Sciences

Gene Network Sciences (GNS) is a privately held biosimulation company with offices in Ithaca, New York, and Cambridge, Massachusetts. Founded in 2000, GNS creates data-driven compound simulation models that help pharmaceutical companies improve the quality of their drug candidates. Leading the company's multi-disciplinary approach are scientists specializing in molecular biology, computer science,...

AmpliMed Corporation

AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma, lung cancer and multiple myeloma. Other products in our portfolio have promise in ovarian, breast, prostate and other common cancers. Our compounds have novel ways of killing cancer cells which are d...

Viropro, Inc.

Viropro, Inc. conducts its operations through its subsidiaries Viropro International, Inc. and Biologics Process Development, Inc. The Company's principal objective and mission is to "make biotech drugs for its clients, efficiently and economically." Towards this end, the Company specializes in the use of its Intellectual Property and high-yield manufactur...

Agilis Consulting Group,LLC

Agilis (from the Latin 'agile') helps clients in the medical industry achieve measurable results with higher customer satisfaction and profits. By carefully applying human factors and human performance principles to your market landscape, we help you differentiate yourself from the competition and attract customers by providing medical products that are safe and responsive to their needs.The FDA r...

Biomedical Technologies Incorporated

BTI Cell Growth Factors & Attachment Factors, BTI Immunoassay Kits, BTI Cell Culture Additives & Components, BTI Lipoproteins/Proteins, BTI Antibodies, BTI [I125] Labeled Compounds & Custom [I125] Radioiodinations.

Arlington Medical Resources

AMR's Hospital Anti-Infectives Insight Series: Gram-Negative Infections analyzes hospital antifungal prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with primary research and extensive understanding of emerging therapies and forecasts. This report contains U.S. data and examines the reasons behind physicians' product preferences, factors driving hosp...

Charles River Laboratories

Charles River Laboratories provides research models and laboratory animal support services, preclinical services, and clinical services to the biomedical market. We are focused on improving human and animal health by becoming the premier global company advancing the search for drugs from discovery through market approval.

Bonovo Orthopedics, Inc.

Bonovo is a leading provider of orthopedic products to the Chinese healthcare market. Bonovo distributes its own products and serves as a distribution partner for other leading international companies. The Bonovo team is committed to driving new standards of orthopedic care throughout China by bringing the best products to market – Products that combi...

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like grow...

EOC Pharma Group

EOC is a fast-growing, Shanghai-based biopharmaceutical company that is focused on the in-licensing of innovative global oncology products, and developing, manufacturing and commercializing them for the China market. The Company is building a fully integrated manufacturing, development and commercialization platform, and has a pipeline of six novel products ...

Xenetic Biosciences Inc.

Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics. Xenetic's proprietary drug technology platforms include PolyXen® for creating next-generation biologic drugs by extending the efficacy, safety and half-life of biologic drugs, and OncoHist® for the development of novel oncolog...

BioChemics, Inc.

BioChemics is a pharmaceutical company that has developed novel topical and transdermal drug delivery systems that for the first time may allow a portfolio of previously transdermally undeliverable drugs to be efficiently delivered through the skin. The drug delivery technology called VALE® (Vaso-active Lipid Encapsulated) may allow many drugs to be re-...

Saniver Limited

Saniver Limited is the very well established company based in China since 1990, dealing with various pharma bulk drugs, veterinary raw materials, extract products, food chemicals, etc. Our head office is located in Hong Kong while our sales office is located in Shanghai with many affiliated offices in different countries world-wide.Based on our very strong financial background, good market strate...

Mendel Biotechnology, Inc

Mendel Biotechnology was founded in early 1997 to develop the idea that controlling gene expression would create new opportunities to improve plant growth and development. We have focused on a large class of genes called transcription factors because they control the degree to which each gene in a cell is activated. The approximately 27,000 genes in the Arabidopsis genome are controlled by approxi...

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders. In January 2006, less than four years after Tercica was founded, we commercially launched Increlex™ (mecasermin [rDNA ...


More From BioPortfolio on "Factors Driving Global Acromegaly Gigantism Drugs Market Technavio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks